249 related articles for article (PubMed ID: 9357813)
1. Intestinal growth is associated with elevated levels of glucagon-like peptide 2 in diabetic rats.
Fischer KD; Dhanvantari S; Drucker DJ; Brubaker PL
Am J Physiol; 1997 Oct; 273(4):E815-20. PubMed ID: 9357813
[TBL] [Abstract][Full Text] [Related]
2. Proglucagon processing in an islet cell line: effects of PC1 overexpression and PC2 depletion.
Dhanvantari S; Brubaker PL
Endocrinology; 1998 Apr; 139(4):1630-7. PubMed ID: 9528943
[TBL] [Abstract][Full Text] [Related]
3. Diabetic intestinal growth adaptation and glucagon-like peptide 2 in the rat: effects of dietary fibre.
Thulesen J; Hartmann B; Nielsen C; Holst JJ; Poulsen SS
Gut; 1999 Nov; 45(5):672-8. PubMed ID: 10517902
[TBL] [Abstract][Full Text] [Related]
4. Role of prohormone convertases in the tissue-specific processing of proglucagon.
Dhanvantari S; Seidah NG; Brubaker PL
Mol Endocrinol; 1996 Apr; 10(4):342-55. PubMed ID: 8721980
[TBL] [Abstract][Full Text] [Related]
5. Enteroglucagon.
Holst JJ
Annu Rev Physiol; 1997; 59():257-71. PubMed ID: 9074764
[TBL] [Abstract][Full Text] [Related]
6. Induction of intestinal epithelial proliferation by glucagon-like peptide 2.
Drucker DJ; Erlich P; Asa SL; Brubaker PL
Proc Natl Acad Sci U S A; 1996 Jul; 93(15):7911-6. PubMed ID: 8755576
[TBL] [Abstract][Full Text] [Related]
7. Role of the prohormone convertase PC3 in the processing of proglucagon to glucagon-like peptide 1.
Rouillé Y; Kantengwa S; Irminger JC; Halban PA
J Biol Chem; 1997 Dec; 272(52):32810-6. PubMed ID: 9407057
[TBL] [Abstract][Full Text] [Related]
8. [Glucagon-like peptides--synthesis, biological actions and some clinical implications].
Otto Buczkowska E; Dworzecki T
Przegl Lek; 2004; 61(9):947-50. PubMed ID: 15803906
[TBL] [Abstract][Full Text] [Related]
9. Methods paper: Performance characteristics of novel assays for circulating levels of proglucagon-derived peptides and validation in a placebo controlled cross-over randomized clinical trial.
Perakakis N; Kalra B; Angelidi AM; Kumar A; Gavrieli A; Yannakoulia M; Mantzoros CS
Metabolism; 2022 Apr; 129():155157. PubMed ID: 35114286
[TBL] [Abstract][Full Text] [Related]
10. Alterations in proglucagon processing and inhibition of proglucagon gene expression in transgenic mice which contain a chimeric proglucagon-SV40 T antigen gene.
Brubaker PL; Lee YC; Drucker DJ
J Biol Chem; 1992 Oct; 267(29):20728-33. PubMed ID: 1328210
[TBL] [Abstract][Full Text] [Related]
11. Involvement of endogenous glucagon-like peptide-1(7-36) amide on glycaemia-lowering effect of oligofructose in streptozotocin-treated rats.
Cani PD; Daubioul CA; Reusens B; Remacle C; Catillon G; Delzenne NM
J Endocrinol; 2005 Jun; 185(3):457-65. PubMed ID: 15930172
[TBL] [Abstract][Full Text] [Related]
12. Central pre-proglucagon derived peptides: opportunities for treatment of obesity.
Larsen PJ; Vrang N; Tang-Christensen M
Curr Pharm Des; 2003; 9(17):1373-82. PubMed ID: 12769729
[TBL] [Abstract][Full Text] [Related]
13. Oxyntomodulin and glicentin: brain-gut peptides in the rat.
Blache P; Kervran A; Bataille D
Endocrinology; 1988 Dec; 123(6):2782-7. PubMed ID: 3197645
[TBL] [Abstract][Full Text] [Related]
14. Distinctive effects of glicentin, GLP-1 and GLP-2 on adaptive response to massive distal small intestine resection in rats.
Hirotani Y; Yamamoto K; Yanaihara C; Balaspiri L; Yanaihara N; Kurokawa K
Ann N Y Acad Sci; 2000; 921():460-3. PubMed ID: 11193876
[No Abstract] [Full Text] [Related]
15. Impaired intestinal proglucagon processing in mice lacking prohormone convertase 1.
Ugleholdt R; Zhu X; Deacon CF; Ørskov C; Steiner DF; Holst JJ
Endocrinology; 2004 Mar; 145(3):1349-55. PubMed ID: 14630721
[TBL] [Abstract][Full Text] [Related]
16. Mucosal adaptation to enteral nutrients is dependent on the physiologic actions of glucagon-like peptide-2 in mice.
Shin ED; Estall JL; Izzo A; Drucker DJ; Brubaker PL
Gastroenterology; 2005 May; 128(5):1340-53. PubMed ID: 15887116
[TBL] [Abstract][Full Text] [Related]
17. Proglucagon-derived peptides in intestinal epithelial proliferation: glucagon-like peptide-2 is a major mediator of intestinal epithelial proliferation in rats.
Ghatei MA; Goodlad RA; Taheri S; Mandir N; Brynes AE; Jordinson M; Bloom SR
Dig Dis Sci; 2001 Jun; 46(6):1255-63. PubMed ID: 11414302
[TBL] [Abstract][Full Text] [Related]
18. Effects of preproglucagon-derived peptides and exendins on steroid-hormone secretion from dispersed adrenocortical cells of normal and streptozotocin-induced diabetic rats.
Malendowicz LK; Spinazzi R; Nussdorfer GG; Trejter M
Int J Mol Med; 2003 Jul; 12(1):115-9. PubMed ID: 12792820
[TBL] [Abstract][Full Text] [Related]
19. Tissue-specific differences in the levels of proglucagon-derived peptides in streptozotocin-induced diabetes.
Brubaker PL; So DC; Drucker DJ
Endocrinology; 1989 Jun; 124(6):3003-9. PubMed ID: 2721455
[TBL] [Abstract][Full Text] [Related]
20. Circulating levels of five proglucagon-derived peptides in response to intravenous or oral glucose or lipids and to a mixed-meal in subjects with normal weight, overweight, and obesity.
Perakakis N; Kokkinos A; Angelidi AM; Tsilingiris D; Gavrieli A; Yannakoulia M; Tentolouris N; Mantzoros CS
Clin Nutr; 2022 Sep; 41(9):1969-1976. PubMed ID: 35961260
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
